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ABSTRACT
Objective Handheld ultrasound devices (HUD) 
has diagnostic value in the assessment of patients 
with suspected left ventricular (LV) dysfunction. This 
meta- analysis evaluates the diagnostic ability of HUD 
compared with transthoracic echocardiography (TTE) and 
assesses the importance of operator experience.
Methods MEDLINE and EMBASE databases were searched 
in October 2020. Diagnostic studies using HUD and TTE 
imaging to determine LV dysfunction were included. Pooled 
sensitivities and specificities, and summary receiver operating 
characteristic curves were used to determine the diagnostic 
ability of HUD and evaluate the impact of operator 
experience on test accuracy.
Results Thirty- three studies with 6062 participants 
were included in the meta- analysis. Experienced 
operators could predict reduced LV ejection fraction 
(LVEF), wall motion abnormality (WMA), LV dilatation 
and LV hypertrophy with pooled sensitivities of 
88%, 85%, 89% and 85%, respectively, and pooled 
specificities of 96%, 95%, 98% and 91%, respectively. 
Non- experienced operators are able to detect cardiac 
abnormalities with reasonable sensitivity and specificity. 
There was a significant difference in the diagnostic 
accuracy between experienced and inexperienced users 
in LV dilatation, LVEF (moderate/severe) and WMA. The 
diagnostic OR for LVEF (moderate/severe), LV dilatation 
and WMA in an experienced hand was 276 (95% CI 58 
to 1320), 225 (95% CI 87 to 578) and 90 (95% CI 31 
to 265), respectively, compared with 41 (95% CI 18 to 
94), 45 (95% CI 16 to 123) and 28 (95% CI 20 to 41), 
respectively, for inexperienced users.
Conclusion This meta- analysis is the first to establish HUD 
as a powerful modality for predicting LV size and function. 
Experienced operators are able to accurately diagnose 
cardiac disease using HUD. A cautious, supervised approach 
should be implemented when imaging is performed by 
inexperienced users. This study provides a strong rationale for 
considering HUD as an auxiliary tool to physical examination 
in secondary care, to aid clinical decision making when 
considering referral for TTE.
Trial registration number CRD42020182429.
INTRODUCTION
Echocardiography is the first- line imaging modality 
for assessing cardiac size and function. Indications 
for transthoracic echocardiography (TTE) as recom-
mended by the British Society of Echocardiography 
and other international societies include but not 
limited to: murmur in the presence of cardiac or 
respiratory symptoms, valvular stenosis or regur-
gitation, ischaemic heart disease, any suspicion of 
heart failure (HF) and arrhythmias.1–3 TTE allows 
determination of left ventricular (LV) dysfunction 
by assessing LV cavity size, wall thickness, valvular 
appearances and function as well as for the presence 
of abnormal blood flow within the heart.4
The miniaturisation of ultrasound technology has 
led to the introduction of handheld cardiac ultra-
sound devices (HUD).5 The portability and acces-
sibility of HUD allow for the augmentation of the 
bedside physical examination. While physical exam-
ination remains the primary method for screening 
cardiovascular disease, the quality and subsequent 
referral to echocardiography depend on the exam-
iner’s experience and skill, or lack thereof.6 HUD 
therefore can bridge the gap between the phys-
ical examination and the more costly and time- 
consuming departmental TTE.
Several recent studies have assessed the perfor-
mance of HUD in diagnosing cardiac disease. The 
aim of this systematic review and meta- analysis is 
to assess the diagnostic accuracy of HUD to detect 
LV abnormalities when compared with TTE in both 
experienced and non- experienced users.
METHODS
The Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses guidelines and the 
Cochrane Handbook of Diagnostic Test Accuracy 
were followed in the study selection, review process 
and evidence synthesis.7 8
Patient and public involvement
Patients or the public were not involved in the 
design, or conduct, or reporting, or dissemination 
plans of our research.
Eligibility criteria
Any study comparing the diagnostic performance of 
HUD and TTE was eligible. The index test was any 
type or size of a HUD performed by operators of 
any level of experience. The reference standard was 
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TTE performed by experienced imagers. Studies were included 
if subjects were aged >18 years, sensitivity, specificity, true posi-
tive and negative and false positive and negative findings were 
reported or if diagnostic data could be extrapolated from the 
results. Studies with a sample size of <20 participants were 
excluded.
Search strategy and study selection
MEDLINE (ProQuest, 1946 to 13 October 2020), EMBASE 
(Ovid, 1974–2020 week 42) were searched on 13 October 2020. 
No search filters were applied. The full search strategy is avail-
able in the online supplemental document. The references of the 
included studies were also screened for relevant studies.
Two authors (SJ and PG) screened the titles and abstracts and 
reviewed full texts for inclusion criteria. Any disagreements were 
discussed with a third author (SA). Data extraction and risk of 
bias analysis was performed by two authors (SJ and PG) and 
disagreements discussed with a third author (SA). Methods for 
the quality assessment of individual studies are detailed in online 
supplemental figure 1.
Statistical analysis
A bivariate random‐effects model was used to obtain the 
summary point for the sensitivity and specificity and estimate 
the corresponding 95% CI and prediction regions for all meta‐
analyses including four or more studies. The metandi command 
in Stata V.16 (StataCorp, College Station, Texas, USA) was used 
to perform the analyses and create summary receiver operating 
characteristics (SROC). The mada package in R was used to 
calculate the diagnostic ORs (DORs) for each study and the 
summary DOR for the pooled results with their respective 95% 
CIs (R Core Team, R: A Language and Environment for Statis-
tical Computing, Vienna, Austria: R Foundation for Statistical 
Computing, 2020). The Wilson method was used to calculate 
the CIs for sensitivities, specificities and false positive rates. The 
Yates correction was used for testing the equality of sensitivi-
ties and specificities. The input for the mada command was the 
number of true positives (TP), false negatives (FN), true nega-
tives (TN) and false postives (FP) for each study.
The effect of operator experience on the effect size of the 
diagnostic accuracy was assessed in a subgroup analysis and 
graphically represented in SROC curves comparing the diag-
nostic accuracy of experienced and inexperienced operators. A 




Our comprehensive search identified 33 studies which were 
incorporated into the meta- analysis. The results of the literature 
search are outlined in the study flow diagram (figure 1).
Description of included studies
All studies had a prospective design, with consecutive or random 
patient selection reported in 21 studies. The studies were 
published between 2002 and 2019. The majority of studies (22 
studies) had a large sample size ≥100 participants, with the 
largest study by Galasko et al8 recruiting 562 patients.9 Indi-
vidual study data incorporated into the meta- analysis can be 
found in online supplemental table 1 and a summary graph of 
the overall risk of bias is shown in online supplemental figure 1.
Study characteristics
A total of 6062 patients conducted in 13 different countries 
were included in the meta- analysis. The mean age of patients 
was 65±5 years with a slight male predominance (54%). Study 
characteristics are presented in table 1. Study- level HUD data 
including sensitivity and specificity to predict reduced LV ejec-
tion fraction (LVEF), wall motion abnormality (WMA), LV 
dilatation and hypertrophy (LVH) are reported in the online 
supplemental materials.
Assessment of methodological quality
The majority of studies (19/25) reported a prospective and 
consecutive or random design. Only one study reported that 
HUD assessors were unblinded to TTE results while three 
studies were judged to incorporate a high risk of bias with TTE 
assessors unblinded to HUD results. There was some concern 
for bias when time between HUD and TTE was >48 hours. One 
study was judged to have a high risk of bias as time between 
HUD and TTE was >7 days.10 The detailed results of the quality 
assessment are outlined in online supplemental figure 2.
Meta-analysis of HUD indices
Each characteristic was separated into subgroups based on the 
investigator’s level of experience. Inexperienced operators were 
those that learnt HUD as part of the study with limited or no 
prior echocardiography experience. This subgroup included 
nurses, medical students, residents, general practitioners and 
inexperienced cardiology trainees. Experienced operators were 
those who had undergone level II/III echocardiography training 
or who were stated to be experienced, expert, or trained in 
echocardiography.
Experienced operators could determine reduced LVEF, LV 
dilatation, WMA and LVH with pooled sensitivities of 88%, 
89%, 85% and 85%, respectively (figures 2–4). In inexperienced 
hands, pooled sensitivities measured were 83%, 68%, 78% and 
80%, respectively. Pooled specificities of HUD by experienced 
Figure 1 The Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses flow chart of literature search.
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users compared with inexperienced users for reduced LVEF, LV 
dilatation, WMA and LVH measured 96% vs 89%, 98% vs 95%, 
95% vs 88% and 91% vs 87%. Online supplemental figure 3 
displays a box plot assessing the pooled accuracy of HUD to 
diagnose moderate/severe LVEF (<45%). SROC curves show an 
improvement in diagnostic accuracy of reduced LVEF, WMA and 
LV dilatation when performed by experienced users (figure 5). 
A summary of the meta- analysis data is provided in table 2. 
The highest diagnostic ORs were in assessing LV dilatation 
(DOR 96, 95% CI 40 to 229). This result indicates that the odds 
of a positive result in a patient with LV dilatation is approxi-
mately 96 times higher than the odds for a positive result in a 
person with no LV dilatation. There was a significant difference in 
the diagnostic accuracy between experienced and inexperienced 
users in LV dilatation, LVEF (moderate/severe) and WMA. The 
DOR for LVEF (moderate/severe), LV dilatation and WMA in an 
experienced hand was 276, 225 and 90, respectively, compared 
with 41, 45 and 28, respectively, for inexperienced users. The 
total effect sizes and subgroup differences test comparing the 
HUD parameters in experienced and inexperienced users are 
shown in online supplemental table 2. A sensitivity analysis 
excluding studies that visually assessed LVH and LV dilatation 
showed that quantitative analysis improves the diagnostic accu-
racy of HUD. Meta- regression analysis confirmed experience to 
be a significant factor in the detection of any degree of LVEF 
dysfunction (p=0.04) and WMA (p=0.01) (online supplemental 
table 3).
Heterogeneity
Heterogeneity can be visualised in all the forest plots depicting 
sensitivity and in the LVEF and LVH plot depicting specificity. 
Despite there being some overlap of CIs, sampling variation 
Table 1 Characteristics of included studies
Study Country Design Study period Size Male (%) Age, years Level of experience HUD
Aldaas et al21 USA Consecutive NR 70 50 61±18 Both Vscan
Alexander et al22 USA NR April–November 
2000
537 53 59 Inexperienced Optigo
Andersen et al23 Norway Random March–September 
2010
108 64 69.1±14 Experienced Vscan
Biais et al24 France Consecutive February–May 
2011
151 35 55±20 Experienced Vscan
Bruce et al9 USA NR NR 374 62 66 Both SonoHeart
Coletta et al25 Italy Consecutive April–June 2003 112 57 61±11 Experienced Optigo
Cullen et al26 USA Consecutive 2012–2013 190 49 62±17 Experienced Vscan
DeCara et al27 USA NR NR 300 NR NR Experienced Optigo
Fedson et al28 USA Consecutive NR 103 NR NR Inexperienced Optigo
Galasko8 UK Consecutive 2000–2001 562 56 62±11 Experienced Optigo
Ghani et al29 USA Consecutive NR 80 51 75±13 Inexperienced Optigo
Giusca et al30 Romania Consecutive NR 56 54 60±12 Inexperienced Acuson P10
Gulič et al31 Slovenia Consecutive NR 200 43 70 Both Vscan
Khan32 USA Consecutive 2012–2013 240 53 71±17 Experienced Vscan
Kirkpatrick33 USA NR NR 63 46 65±16 Inexperienced Optigo
Kobal et al34 USA Consecutive NR 61 62 70±19 Inexperienced Optigo
Liebo35 USA Consecutive February–March 
2010
97 45 68±17 Both Vscan
López- Palmero et al36 Spain NR July–December 
2013
223 42 76 Inexperienced Vscan
Lucas et al37 USA Consecutive March–May 2007 322 53 56±13 Inexperienced Micromaxx
Lucas et al38 USA Consecutive 2008–2009 210 55 55 Inexperienced NR
Martin et al39 USA Consecutive 2004–2005 354 47 63±19 Inexperienced Sonosite Elite
Mehta et al40 USA NR NR 250 66 61±15 Experienced Vscan
Mjølstad et al41 Norway Consecutive April–June 2011 199 54 66±18 Inexperienced Vscan
Nilsson et al42 Sweden NR 2016–2017 100 55 70±12 Inexperienced Vscan
Olesen43 Denmark NR NR 260 49 80 Experienced Vscan
Perez- Avraham et al44 Israel Consecutive July–December 
2004
85 37 59±14 Inexperienced Optigo
Razi et al45 USA Consecutive NR 50 58 57±17 Inexperienced Vscan
Ruddox et al46 Norway NR 2011–2012 303 61 73 Inexperienced Vscan
Stokke et al13 Norway Random February–May 
2012
72 72 65±16 Both Vscan
Vignon et al47 France Consecutive NR 55 69 61±16 Experienced SonoHeart
Vourvouri et al48 The Netherlands Consecutive NR 88 64 59±12 Experienced SonoHeart or Optigo
Wejner- Mik et al49 Poland Consecutive NR 87 67 61±16 Experienced Lumify
Xie et al50 USA Consecutive NR 100 55 59±17 Experienced SonoHeart
HUD, handheld ultrasound devices; NR, not reported.
 on A














4 Jenkins S, et al. Heart 2021;0:1–9. doi:10.1136/heartjnl-2021-319561
Heart failure and cardiomyopathies
does not completely explain the differences between studies. 
This apparent heterogeneity can also be observed in the SROC 
curves for LVEF, WMA and LV dilatation. The increased hetero-
geneity in the sensitivity plots may be partly explained by fewer 
patients with the target condition than without. This provides 
less certainty and results in wider CIs.
A negative correlation between sensitivity and specificity 
was shown in the meta- analysis of LVEF<45%, WMA and LV 
dilatation indicating no significant heterogeneity. The correla-
tion coefficients for LVEF (any abnormality) and LVH was 
positive indicating the presence of possible heterogeneity in 
the results. We planned to assess the effect of operator experi-
ence, pre- existing comorbidities and baseline LV function on the 
results in a meta- regression covariate analysis. However, only 
operator experience was sufficiently reported and showed that 
experience was a significant factor in detecting LVEF, WMA and 
LV dilatation.
Variation in thresholds likely accounts for some heterogeneity 
when measuring LVEF (any abnormality), LV dilatation and 
LVH. Studies with both qualitative and quantitative method-
ologies were incorporated into the meta- analysis. Quantitative 
thresholds of LV dilatation ranged from >53 mm to >59 mm, 
with some studies classifying LV dilatation subject to gender. 
Similarly, studies measuring LVH were both qualitative and quan-
titative, with thresholds ranging from >10 mm to >12 mm. A 
sensitivity analysis excluding qualitative assessment of LVH and 
LV dilatation showed an improvement in the diagnostic accuracy 
(online supplemental table 3).
Other sources of heterogeneity may also exist that cannot be 
assessed including functionality and technological advancement 
Figure 2 Meta- analyses of left ventricular ejection fraction (LVEF) and left ventricular (LV) dilatation. Sensitivity and specificity (95% CI) values are 
reported.
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of handheld devices that may allow for more accurate results to 
be obtained. Some studies reported any abnormality in LVEF 
as a positive finding without quantifying the results into mild, 
moderate or severe, which may have led to heterogeneity between 
studies. However, to limit the effect of the possible heterogeneity 
we analysed studies reporting LVEF <45% (moderate and severe 
degrees of LV dysfunction) separately. This analysis allowed for a 
detailed assessment of HUD in significant disease.
Varying levels of experience using HUD by experienced echo-
cardiographers may account for some heterogeneity. The level 
and volume of training received by non- experienced users prior 
to each study was also variable adding to heterogeneity within 
the non- experienced subgroup.
DISCUSSION
To the best of our knowledge, this is the first meta- analysis of 
the diagnostic accuracy of HUD for imaging LV cardiac struc-
tural and functional abnormalities and the first to report the 
impact of user experience. The meta- analysis shows that HUD 
is both a sensitive and specific method for assessing LV func-
tion and morphology when performed by experienced opera-
tors. While a basic competence in HUD can be achieved in a 
relatively short period of time, in clinical practice, a cautious, 
supervised approach should be applied when inexperienced 
users are acquiring and interpreting images. This mostly applies 
to secondary care where the prevalence of disease and the avail-
ability of experienced echocardiographers is greatest. Our find-
ings demonstrate that HUD is a valuable bedside tool that can 
be used to identify those who require further investigation and 
as a result may lead to a reduction in the number of unnecessary 
echo referrals (table 3).
Training is required to be able to use HUD competently and 
therefore the results of our study should be interpreted based 
on the level of operator experience. The amount of training 
offered and ability to practise using HUD will also impact 
the diagnostic outcome that can be expected. Operators with 
limited training however were less able to detect LV dilata-
tion and WMA, recording pooled sensitivities of 68% and 
78%, respectively compared with 89% and 85% achieved by 
experienced echocardiographers. A positive scan in an expe-
rienced hand had a 3–6 times higher odds of showing true LV 
impairment, LV dilatation or WMA compared with inexpe-
rienced operators. Operator experience was not a significant 
discriminating factor when measuring LVH suggesting that it 
Figure 3 Meta- analyses of wall motion abnormality (WMA) and left ventricular hypertrophy (LVH). Sensitivity and specificity (95% CI) values are 
reported.
 on A














6 Jenkins S, et al. Heart 2021;0:1–9. doi:10.1136/heartjnl-2021-319561
Heart failure and cardiomyopathies
can be more accurately measured by clinicians with minimal 
training.
Important logistical points need to be considered including 
cost- effectiveness, training and accessibility by clinicians. HUD 
has been shown to be more cost- effective in comparison to TTE 
and reduces overall costs when compared with physical exam-
ination.6 11 Despite these potential savings, implementation 
requires training and frequent revalidation to maintain the clini-
cian’s skill. Didactic and practical sessions are required before 
clinicians can achieve basic competence in HUD. A minimum 
of 30 scans has been recommended, however brief training is 
associated with an increased false- positive rate.12 13 This first 
highlights that HUD performed by inexperienced users should 
be supervised by experienced echocardiographers as previously 
mentioned and second, the importance of frequent training 
and consolidation in echocardiography before allowing users 
to image patients without supervision. Accessibility of recorded 
images is therefore a fundamental property of a HUD if suffi-
cient supervision is to be achieved.
Our data suggest that HUD is best positioned at the beginning 
of the clinical pathway when suspicious of cardiac pathology, 
thus augmenting the cardiovascular examination. Detecting 
cardiac disease earlier, when the prevalence of any abnormality 
is at its lowest, is likely to incur higher rates of false positives. 
However, HUD should be considered as a method of triaging 
patients who may require further investigation. HUD should not 
be considered as a replacement to TTE. HUD can be conducted 
at the bedside and take <6 min.14 It can be argued that this is 
preferable compared with the potential of unnecessarily having 
to wait for a more complex scan, which may require the patient 
to return on a separate day or result in a longer stay in hospital. 
However, a negative finding on HUD and not proceeding to full 
TTE risks cardiac abnormalities being missed, a factor which 
should be considered on an individual patient basis.
Negative results (ie, specificity) can be used with reason-
able confidence used to determine normal cardiac physiology. 
However, positive results need to be interpreted with caution, 
especially when performed by inexperienced HUD users. Clin-
ical decision making should not be solely guided by the interpre-
tation of HUD images, even by experienced echocardiographers. 
Instead, these results suggest that HUD should act as an initial 
Figure 4 Summary receiver operating characteristic curve (SROC) for 
the pooled sensitivity and specificity with the summary point for the 
different handheld ultrasound devices assessments. HSROC, hierarchical 
summary receiver operator curves; LVEF, left ventricular ejection fraction; 
LVH, left ventricular hypertrophy; LV, left ventricular; WMA, wall motion 
abnormality.
Figure 5 Summary receiver operating characteristic curves for LV 
parameters comparing effect user experience on handheld ultrasound 
devices diagnostic accuracy. LVEF, left ventricular ejection fraction; LV, 
left ventricular; WMA, wall motion abnormality.
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diagnostic test to aid decision making on whether further inves-
tigation, including TTE, and treatment is required.
Given the excellent sensitivity and specificity particularly seen 
with more experienced operators, it is likely that the role of 
HUD will become even more prominent in future clinical prac-
tice. We would support earlier teaching and training of HUD 
and its incorporation into the medical school curriculum, thus 
providing an important way of ensuring adequate training for 
all future doctors.
Strengths and limitations
An extensive literature search was performed. No search filters 
were used revealing results from an unpublished source, thus 
minimising the risk of publication bias. To limit the effect of any 
reporting bias, data were carefully extracted from the results of 
some studies that did not explicitly state sensitivity and speci-
ficity values. The search and data extraction were performed by 
two authors independently to minimise the bias in the review 
process.
Half of the included studies are >10 years old and improve-
ment in screen technology, image processing and other advance-
ments might play a pivotal role in improving the diagnostic 
accuracy of HUD.
The lack of a common threshold for WMA, LV dilatation 
and LVH means the diagnostic performance may vary between 
centres. Our results do however show that despite variation in 
thresholds, the specificity of HUD remains ≥87% for all char-
acteristics. Even if sensitivity is reduced, the use of HUD as an 
initial diagnostic tool means diagnosing a condition and deter-
mining disease severity is not the aim of this test. Any uncer-
tainty when interpreting the image should result in referral for 
further investigation. Clinical suspicion of HF and measurement 
of LV filling pressures is an important indication for echocar-
diography assessment and would be a valuable bedside tool. 
Clarius is one of the only scanners on the market capable of 
pulse- wave Doppler (PWD), permitted by the installation of a 
liquid heating device which prevents overheating.15 The current 
technological capabilities of most HUDs do not include PWD 
and therefore filling pressures cannot be measured using these 
devices.16 We were therefore unable to analyse sufficient data 
regarding this variable.
Future applications
With advancement of technology, LV border tracking and other 
methods of automatic, device- generated, quantitative measures 
of ejection fraction may become routinely available.17 Incorpo-
ration of PWD and continuous- wave Doppler technology into 
a greater number of available HUDs will also allow for a more 
extensive range of quantitative cardiovascular assessments to be 
undertaken at the bedside. Qualitative assessment of valvular 
heart disease using colour- flow Doppler is available on most 
HUDs, however is outside the scope of this review. Images may 
Table 2 Results of meta- analyses comparing the diagnostic accuracy of HUD with first- line TTE





CI) Studies (n) Prevalence
Sensitivity (95% 
CI) Studies (n) Prevalence
Sensitivity 
(95% CI)
LVEF (any abnormality) 15 (2936) 0.23 86 (80 to 90) 9 (1406) 0.18 88 (81 to 92) 9 (1530) 0.28 83 (71 to 90)
LVEF (moderate/severe) 10 (1611) 0.27 91 (86 to 94) 5 (722) 0.27 93 (89 to 96) 7 (889) 0.27 84 (72 to 92)
WMA 13 (1931) 0.27 81 (74 to 85) 6 (794) 0.26 85 (76 to 91) 7 (1137) 0.28 78 (70 to 84)
LV dilatation 10 (1966) 0.13 73 (59 to 84) 6 (966) 0.17 89 (64 to 97) 6 (1000) 0.09 68 (51 to 81)
LVH 12 (2229) 0.24 83 (73 to 90) 6 (1096) 0.23 85 (72 to 92) 7 (1133) 0.26 80 (61 to 91)
LVEF (any abnormality) 14 (2851) 0.21 91 (87 to 95) 8 (1368) 0.16 96 (90 to 98) 8 (1483) 0.26 89 (81 to 93)
LVEF (moderate/severe) 10 (1611) 0.27 92 (87 to 96) 5 (722) 0.27 96 (87 to 99) 7 (889) 0.27 91 (83 to 95)
WMA 12 (1876) 0.28 90 (88 to 92) 6 (759) 0.27 95 (93 to 96) 6 (1117) 0.28 88 (85 to 90)
LV dilatation 10 (1966) 0.13 95 (94 to 97) 6 (966) 0.17 98 (93 to 99) 6 (1000) 0.09 95 (93 to 96)
LVH 11 (2228) 0.25 90 (82 to 95) 5 (1095) 0.23 91 (82 to 96) 7 (1133) 0.26 87 (67 to 96)
HUD, handheld ultrasound devices; LV, left ventricular; LVEF, LV ejection fraction; LVH, LV dilatation and hypertrophy; TTE, transthoracic echocardiography; WMA, wall motion 
abnormalities.
Table 3 Summary of findings
Review question Is handheld echocardiography able to accurately diagnose LV dysfunction compared with TTE?
Population 6062 participants aged 65±5 years with a male predominance of 54% requiring routine referral for TTE
Setting Single centres with access to TTE
Studies Studies of diagnostic tests
Quality of evidence Majority of studies reported consecutive or random sampling, blinding of assessors and short time between HUD and TTE imaging (24–28 hours)
Pooled results Sensitivity (95% CI) Specificity (95% CI)
  Experienced Inexperienced Experienced Inexperienced
LVEF (any abnormality) 88 (81 to 92) 83 (71 to 90) 96 (90 to 98) 89 (81 to 93)
LVEF (moderate/severe) 93 (89 to 96) 84 (72 to 92) 96 (87 to 99) 91 (83 to 95)
WMA 85 (76 to 91) 78 (70 to 84) 95 (93 to 96) 88 (85 to 90)
LV dilatation 89 (64 to 97) 68 (51 to 81) 98 (93 to 99) 95 (93 to 96)
LVH 85 (72 to 92) 80 (61 to 91) 91 (82 to 96) 87 (67 to 96)
HUD, handheld ultrasound devices; LV, left ventricular; LVEF, LV ejection fraction; LVH, LV dilatation and hypertrophy; TTE, transthoracic echocardiography; WMA, wall motion 
abnormalities.
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ultimately be sent remotely following acquisition directly to an 
experienced echocardiographer who can review and interpret 
images immediately, fast- tracking patients who require further 
investigation.18 19 Further developments in HUD therefore 
have the potential to revolutionise the bedside cardiovascular 
examination.
This study highlights the need to further develop methods to 
bridge the gap between experienced and inexperienced users. 
Education and introduction of an ultrasound curriculum for 
medical students and junior doctors can improve understanding 
of clinical anatomy, develop basic ultrasound skills and later their 
diagnostic ability.20 21 Formulation of a designated HUD training 
pathway would allow for standardisation of HUD competencies 
and provide structure to those wishing to advance their experi-
ence using HUDs. These suggestions are limited by the finan-
cial burden this would incur as well as a shortfall of clinicians 
adequately trained using HUDs.
CONCLUSION
This meta- analysis supports the use of HUD as a powerful 
modality for predicting LV size and systolic function. HUD diag-
nostic yield is superior when performed by experienced echo-
cardiographers. Images acquired by an inexperienced operator 
should be done under direct supervision or validated by a more 
experienced user. This study provides a strong rationale for 
considering HUD as an auxiliary tool to the physical examina-
tion in secondary care, to aid the clinical decision making when 
considering referral for TTE.
Key messages
What is already known on this subject?
 ► Handheld cardiac ultrasound device (HUD) offers rapid 
bedside assessment of cardiac morphology and function.
 ► The diagnostic accuracy of HUD previously reported has 
shown heterogeneity between studies and its clinical value 
has yet to be determined.
What might this study add?
 ► To the best of our knowledge, this is the first study to perform 
a meta- analysis evaluating the diagnostic accuracy of HUD 
devices to detect cardiac dysfunction and the impact of 
operator experience on test accuracy.
 ► This study reports that HUD test accuracy is significantly 
improved when performed by experienced operators.
How might this impact on clinical practice?
 ► The clinical utility of HUD is rapidly expanding.
 ► Augmentation of the physical cardiovascular examination 
using HUD may improve detection of cardiac size and 
function at the bedside and lead to a reduction in the number 
of unnecessary departmental transthoracic echocardiography 
referrals.
 ► Image interpretation by inexperienced operators should be 
confirmed by more experienced echocardiographers before 
clinical decisions and referral for further imaging are made.
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